Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
If you have an existing liver condition, you must seek medical advice
Until comprehensive carcinogenicity studies are completed, individuals with active cancer, cancer history, or high genetic cancer risk should avoid BPC-157
Greig SL
As of August 3, 2026, retatrutide remained investigational and was not approved by the FDA
Symptoms include localized redness, swelling, warmth, and pain at the injection site
US$ 29.20
US$ 22.36
US$ 28.59
